APO RESEARCH · REPORT
Albumin
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Product & engineering
Understand the product.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Selected research
Industry Growth & Trends
Global Albumin Industry Growth and Trends Forecast to 2032
Market perspective
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Albumin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Albumin market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Albumin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Albumin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Albumin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Albumin Market by Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Albumin Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Albumin Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Albumin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Applications
- Therapeutics
- Vaccine Ingredient
- Culture Medium Ingredient
- Others
Companies covered
- CSL
- Grifols
- Shire (Baxalta)
- Octapharma
- Hualan Bio
- CBPO
- RAAS
- Kedrion
- Merck
- LFB Group
- Albumedix
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Albumin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Albumin Sales Estimates and Forecasts (2021-2032)
- 1.3 Albumin Market by Type
- 1.3.1 Human Serum Albumin
- 1.3.2 Bovine Serum Albumin
- 1.3.3 Recombinant Albumin
- 1.4 Global Albumin Market Size by Type
- 1.4.1 Global Albumin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Albumin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Albumin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Albumin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Albumin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Albumin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Albumin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Albumin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Albumin Industry Trends
- 2.2 Albumin Industry Drivers
- 2.3 Albumin Industry Opportunities and Challenges
- 2.4 Albumin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Albumin Revenue (2021-2026)
- 3.2 Global Top Players by Albumin Sales (2021-2026)
- 3.3 Global Top Players by Albumin Price (2021-2026)
- 3.4 Global Albumin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Albumin Major Company Production Sites & Headquarters
- 3.6 Global Albumin Company, Product Type & Application
- 3.7 Global Albumin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Albumin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Albumin Players Market Share by Revenue in 2025
- 3.8.3 2025 Albumin Tier 1, Tier 2, and Tier 3
4 Albumin Regional Status and Outlook
- 4.1 Global Albumin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Albumin Historic Market Size by Region
- 4.2.1 Global Albumin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Albumin Sales in Value by Region (2021-2026)
- 4.2.3 Global Albumin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Albumin Forecasted Market Size by Region
- 4.3.1 Global Albumin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Albumin Sales in Value by Region (2027-2032)
- 4.3.3 Global Albumin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Albumin by Application
- 5.1 Albumin Market by Application
- 5.1.1 Therapeutics
- 5.1.2 Vaccine Ingredient
- 5.1.3 Culture Medium Ingredient
- 5.1.4 Others
- 5.2 Global Albumin Market Size by Application
- 5.2.1 Global Albumin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Albumin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Albumin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Albumin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Albumin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Albumin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Albumin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Albumin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 CSL
- 6.1.1 CSL Company Information
- 6.1.2 CSL Business Overview
- 6.1.3 CSL Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 CSL Albumin Product Portfolio
- 6.1.5 CSL Recent Developments
- 6.2 Grifols
- 6.2.1 Grifols Company Information
- 6.2.2 Grifols Business Overview
- 6.2.3 Grifols Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Grifols Albumin Product Portfolio
- 6.2.5 Grifols Recent Developments
- 6.3 Shire (Baxalta)
- 6.3.1 Shire (Baxalta) Company Information
- 6.3.2 Shire (Baxalta) Business Overview
- 6.3.3 Shire (Baxalta) Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shire (Baxalta) Albumin Product Portfolio
- 6.3.5 Shire (Baxalta) Recent Developments
- 6.4 Octapharma
- 6.4.1 Octapharma Company Information
- 6.4.2 Octapharma Business Overview
- 6.4.3 Octapharma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Octapharma Albumin Product Portfolio
- 6.4.5 Octapharma Recent Developments
- 6.5 Hualan Bio
- 6.5.1 Hualan Bio Company Information
- 6.5.2 Hualan Bio Business Overview
- 6.5.3 Hualan Bio Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hualan Bio Albumin Product Portfolio
- 6.5.5 Hualan Bio Recent Developments
- 6.6 CBPO
- 6.6.1 CBPO Company Information
- 6.6.2 CBPO Business Overview
- 6.6.3 CBPO Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CBPO Albumin Product Portfolio
- 6.6.5 CBPO Recent Developments
- 6.7 RAAS
- 6.7.1 RAAS Company Information
- 6.7.2 RAAS Business Overview
- 6.7.3 RAAS Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 RAAS Albumin Product Portfolio
- 6.7.5 RAAS Recent Developments
- 6.8 Kedrion
- 6.8.1 Kedrion Company Information
- 6.8.2 Kedrion Business Overview
- 6.8.3 Kedrion Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Kedrion Albumin Product Portfolio
- 6.8.5 Kedrion Recent Developments
- 6.9 Merck
- 6.9.1 Merck Company Information
- 6.9.2 Merck Business Overview
- 6.9.3 Merck Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Merck Albumin Product Portfolio
- 6.9.5 Merck Recent Developments
- 6.10 LFB Group
- 6.10.1 LFB Group Company Information
- 6.10.2 LFB Group Business Overview
- 6.10.3 LFB Group Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 LFB Group Albumin Product Portfolio
- 6.10.5 LFB Group Recent Developments
- 6.11 Albumedix
- 6.11.1 Albumedix Company Information
- 6.11.2 Albumedix Business Overview
- 6.11.3 Albumedix Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Albumedix Albumin Product Portfolio
- 6.11.5 Albumedix Recent Developments
- 6.12 Thermo Fisher Scientific
- 6.12.1 Thermo Fisher Scientific Company Information
- 6.12.2 Thermo Fisher Scientific Business Overview
- 6.12.3 Thermo Fisher Scientific Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Thermo Fisher Scientific Albumin Product Portfolio
- 6.12.5 Thermo Fisher Scientific Recent Developments
7 North America by Country
- 7.1 North America Albumin Sales by Country
- 7.1.1 North America Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Albumin Sales by Country (2021-2026)
- 7.1.3 North America Albumin Sales Forecast by Country (2027-2032)
- 7.2 North America Albumin Market Size by Country
- 7.2.1 North America Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Albumin Market Size by Country (2021-2026)
- 7.2.3 North America Albumin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Albumin Sales by Country
- 8.1.1 Europe Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Albumin Sales by Country (2021-2026)
- 8.1.3 Europe Albumin Sales Forecast by Country (2027-2032)
- 8.2 Europe Albumin Market Size by Country
- 8.2.1 Europe Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Albumin Market Size by Country (2021-2026)
- 8.2.3 Europe Albumin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Albumin Sales by Country
- 9.1.1 Asia-Pacific Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Albumin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Albumin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Albumin Market Size by Country
- 9.2.1 Asia-Pacific Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Albumin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Albumin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Albumin Sales by Country
- 10.1.1 South America Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Albumin Sales by Country (2021-2026)
- 10.1.3 South America Albumin Sales Forecast by Country (2027-2032)
- 10.2 South America Albumin Market Size by Country
- 10.2.1 South America Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Albumin Market Size by Country (2021-2026)
- 10.2.3 South America Albumin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Albumin Sales by Country
- 11.1.1 Middle East and Africa Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Albumin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Albumin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Albumin Market Size by Country
- 11.2.1 Middle East and Africa Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Albumin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Albumin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Albumin Value Chain Analysis
- 12.1.1 Albumin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Albumin Production Mode & Process
- 12.2 Albumin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Albumin Distributors
- 12.2.3 Albumin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst